Different Cholinesterase Inhibitor Effects on CSF Cholinesterases in Alzheimer Patients

Agneta Nordberg, Taher Darreh‐Shori, Elaine R. Peskind, Hilkka Soininen, Malahat Mousavi, Gina Eagle, Roger Lane

Current Alzheimer Research · 2009 · 75 citations · 43 references

DOIFull text

Open access

Abstract

The findings suggest pharmacologically-induced differences between rivastigmine, donepezil and galantamine. Rivastigmine provides sustained inhibition of AChE and BuChE, while donepezil and galantamine do not inhibit BuChE and are associated with increases in CSF AChE protein levels. The clinical implications require evaluation.

References

43